Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk

1 Jan 2020

Abstract excerpt

Over 35% of the adult US population is obese. In turn, excess adiposity increases the risk of multiple complications including type 2 diabetes (T2D), insulin resistance, and cardiovascular disease; yet, obesity also independently heightens risk of Alzheimer's Disease (AD), even after adjusting for other important confounding risk factors including blood pressure, sociodemographics, cholesterol levels, smoking...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Clusterin in disease pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33110346
DOI: 10.1177/1177271920964108

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease RiskPMID 33110346Read ↗

Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other PathologiesSemantic proximity Read ↗

Pathways to Alzheimer’s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal HealthSemantic proximity Read ↗

The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and TherapySemantic proximity Read ↗

Plasma clusterin and the risk of Alzheimer disease.Semantic proximity Read ↗

Clusterin is a Potential Therapeutic Target in Alzheimer’s DiseaseSemantic proximity Read ↗

Clusterin in Alzheimer’s disease: a player in the biological behavior of amyloid-betaSemantic proximity Read ↗

Obesity impacts the expression of Alzheimer's disease–related genes: The Framingham Heart StudySemantic proximity Read ↗

Clusterin levels are increased in <scp>A</scp>lzheimer's disease and influence the regional distribution of A<b>β</b>Semantic proximity Read ↗

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.Semantic proximity Read ↗

Spotlight on the Pathophysiological Trajectories Linked to Alzheimer’s Disease (AD): Blood-Brain Barrier (BBB); Neuroinflammation; APOE4 Allele and AD- Insulin Resistance (IR) Pathogenic LinkSemantic proximity Read ↗

Obesity-related brain atrophy is independent of Alzheimer’s disease protein pathwaysSemantic proximity Read ↗

The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.